Efter vurdering af alle tilgængelige data fandt CHMP, at brugen af valsartan 80 mg som startdosis uden dosisjustering hos patienter med nedsat nyrefunktion (kreatininclearance > 10 ml/ min)
Having assessed the data available, the CHMP considered that the use of valsartan 80 mg as the starting dose, with no dosage adjustment, in patients with reduced renal function (creatinine